Adagene • ADAG
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Peter Luo, PhD$102M
Market Cap • 06/05/20242011
(há 13 anos)
2021
(3 years ago)
NASDAQ
Listagem
Suzhou
248
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ADAGSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.